What is the outlook for Compugen CGEN stock today Climbs Higher 20260427 Is Rein Therapeutics RNTX stock testing important levels Q4 2025 Profit Disappoints OPRT Oportun beats Q4 2025 EPS estimates by 103 percent shares gain 191 percent in todays session